Nathaniel I. Martin, Ph.D. - Publications

2004 University of Alberta, Edmonton, Alberta, Canada 
 2007-2018 Chemistry Utrecht University, Utrecht, Netherlands 
 2018- Biological Chemisyr Leiden University, Leiden, Netherlands 
Chemical biology

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Machushynets NV, Al Ayed K, Terlouw BR, Du C, Buijs NP, Willemse J, Elsayed SS, Schill J, Trebosc V, Pieren M, Alexander FM, Cochrane SA, Liles MR, Medema MH, Martin NI, et al. Discovery and Derivatization of Tridecaptin Antibiotics with Altered Host Specificity and Enhanced Bioactivity. Acs Chemical Biology. PMID 38602492 DOI: 10.1021/acschembio.4c00034  0.778
2023 Buijs NP, Matheson EJ, Cochrane SA, Martin NI. Targeting membrane-bound bacterial cell wall precursors: a tried and true antibiotic strategy in nature and the clinic. Chemical Communications (Cambridge, England). PMID 37219335 DOI: 10.1039/d3cc01070h  0.71
2023 Ballantine RD, Al Ayed K, Bann SJ, Hoekstra M, Martin NI, Cochrane SA. Linearization of the Brevicidine and Laterocidine Lipopeptides Yields Analogues That Retain Full Antibacterial Activity. Journal of Medicinal Chemistry. PMID 37071814 DOI: 10.1021/acs.jmedchem.3c00308  0.787
2023 Deisinger JP, Arts M, Kotsogianni I, Puls JS, Grein F, Ortiz-López FJ, Martin NI, Müller A, Genilloud O, Schneider T. Dual targeting of the class V lanthipeptide antibiotic cacaoidin. Iscience. 26: 106394. PMID 37013189 DOI: 10.1016/j.isci.2023.106394  0.321
2023 Al Ayed K, Zamarbide Losada D, Machushynets NV, Terlouw B, Elsayed SS, Schill J, Trebosc V, Pieren M, Medema MH, van Wezel GP, Martin NI. Total Synthesis and Structure Assignment of the Relacidine Lipopeptide Antibiotics and Preparation of Analogues with Enhanced Stability. Acs Infectious Diseases. PMID 37000899 DOI: 10.1021/acsinfecdis.3c00043  0.805
2022 Ballantine RD, Al Ayed K, Bann SJ, Hoekstra M, Martin NI, Cochrane SA. Synthesis and structure-activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine. Rsc Medicinal Chemistry. 13: 1640-1643. PMID 36545437 DOI: 10.1039/d2md00281g  0.795
2022 Slingerland CJ, Wesseling CMJ, Innocenti P, Westphal KGC, Masereeuw R, Martin NI. Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids. Journal of Medicinal Chemistry. 65: 15878-15892. PMID 36399613 DOI: 10.1021/acs.jmedchem.2c01528  0.301
2022 Buijs N, Vlaming H, van Haren M, Martin NI. Synthetic Studies with Bacitracin A and Preparation of Analogues Containing Alternative Zinc Binding Groups. Chembiochem : a European Journal of Chemical Biology. PMID 36287040 DOI: 10.1002/cbic.202200547  0.325
2022 Al Ayed K, Ballantine RD, Hoekstra M, Bann SJ, Wesseling CMJ, Bakker AT, Zhong Z, Li YX, Brüchle NC, van der Stelt M, Cochrane SA, Martin NI. Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and efficacy. Chemical Science. 13: 3563-3570. PMID 35432860 DOI: 10.1039/d2sc00143h  0.79
2021 Kotsogianni I, Wood TM, Alexander FM, Cochrane SA, Martin NI. Binding Studies Reveal Phospholipid Specificity and Its Role in the Calcium-Dependent Mechanism of Action of Daptomycin. Acs Infectious Diseases. PMID 34406007 DOI: 10.1021/acsinfecdis.1c00316  0.702
2020 Tehrani KHME, Brüchle NC, Wade N, Mashayekhi V, Pesce D, van Haren MJ, Martin NI. Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem. Acs Infectious Diseases. PMID 32227874 DOI: 10.1021/Acsinfecdis.9B00459  0.363
2020 Tehrani KHME, Fu H, Brüchle NC, Mashayekhi V, Prats Luján A, van Haren MJ, Poelarends GJ, Martin NI. Aminocarboxylic acids related to aspergillomarasmine A (AMA) and ethylenediamine-N,N'-disuccinic acid (EDDS) are strong zinc-binders and inhibitors of the metallo-beta-lactamase NDM-1. Chemical Communications (Cambridge, England). PMID 32048688 DOI: 10.1039/D0Cc00356E  0.361
2019 Wood TM, Bertheussen K, Martin NI. The contribution of achiral residues in the laspartomycin family of calcium-dependent lipopeptide antibiotics. Organic & Biomolecular Chemistry. PMID 31854417 DOI: 10.1039/C9Ob02534K  0.377
2019 Chiorean S, Antwi I, Carney DW, Kotsogianni I, Giltrap AM, Alexander FM, Cochrane SA, Payne RJ, Martin NI, Henninot A, Vederas JC. Dissecting the binding interactions of teixobactin with the bacterial cell wall precursor lipid II. Chembiochem : a European Journal of Chemical Biology. PMID 31552694 DOI: 10.1002/Cbic.201900504  0.773
2019 Zhang Y, van Haren MJ, Martin NI. Peptidic transition state analogues as PRMT inhibitors. Methods (San Diego, Calif.). PMID 31421210 DOI: 10.1016/J.Ymeth.2019.08.003  0.372
2019 Gao Y, van Haren M, Moret EE, Rood JJM, Sartini D, Salvucci A, Emanuelli M, Craveur P, Babault N, Jin J, Martin NI. Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity. Journal of Medicinal Chemistry. PMID 31265285 DOI: 10.1021/Acs.Jmedchem.9B00413  0.37
2019 Wood TM, Martin NI. The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry. Medchemcomm. 10: 634-646. PMID 31191855 DOI: 10.1039/C9Md00126C  0.35
2019 Brouwer MSM, Tehrani KHME, Rapallini M, Geurts Y, Kant A, Harders F, Mashayekhi V, Martin NI, Bossers A, Mevius DJ, Wit B, Veldman KT. Novel carbapenemase FLC-1 and IMI-2 encoded by an complex isolated from food products. Antimicrobial Agents and Chemotherapy. PMID 30910900 DOI: 10.1128/Aac.02338-18  0.33
2019 Garcia Fernandez JM, Mena-Barragán T, Isabel García-Moreno M, Sevšek A, Okazaki T, Nanba E, Higaki K, Martin NI, Pieters RJ, Mellet CO, Suzuki Y. Tailoring the inhibitory versus chaperoning behavior of amphiphilic sp-iminosugar glycomimetics targeting β-glucocerebrosidase: From micromolar to picomolar chaperones for Gaucher disease Molecular Genetics and Metabolism. 126: S58. DOI: 10.1016/J.Ymgme.2018.12.133  0.519
2018 Lin MH, Potel CM, Tehrani KHME, Heck AJR, Martin NI, Lemeer S. A new tool to reveal bacterial signaling mechanisms in antibiotic treatment and resistance. Molecular & Cellular Proteomics : McP. PMID 30232125 DOI: 10.1074/Mcp.Ra118.000880  0.323
2018 Bolt HL, Kleijn LHJ, Martin NI, Cobb SL. Synthesis of Antibacterial Nisin⁻Peptoid Hybrids Using Click Methodology. Molecules (Basel, Switzerland). 23. PMID 29958423 DOI: 10.3390/Molecules23071566  0.412
2018 Mena-Barragán T, García-Moreno MI, Sevšek A, Okazaki T, Nanba E, Higaki K, Martin NI, Pieters RJ, Fernández JMG, Mellet CO. Probing the Inhibitor versus Chaperone Properties of sp²-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease. Molecules (Basel, Switzerland). 23. PMID 29673163 DOI: 10.3390/Molecules23040927  0.603
2018 van Haren MJ, Thomas MG, Sartini D, Barlow DJ, Ramsden DB, Emanuelli M, Klamt F, Martin NI, Parsons RB. The kinetic analysis of the N-methylation of 4-phenylpyridine by nicotinamide N-Methyltransferase: evidence for a novel mechanism of substrate inhibition. The International Journal of Biochemistry & Cell Biology. PMID 29549048 DOI: 10.1016/J.Biocel.2018.03.010  0.334
2017 Sevšek A, Sastre Toraño J, Quarles van Ufford L, Moret EE, Pieters RJ, Martin NI. Orthoester functionalized -guanidino derivatives of 1,5-dideoxy-1,5-imino-d-xylitol as pH-responsive inhibitors of β-glucocerebrosidase. Medchemcomm. 8: 2050-2054. PMID 30108721 DOI: 10.1039/C7Md00480J  0.568
2017 't Hart P, Wood TM, Tehrani KHME, van Harten RM, Śleszyńska M, Rentero Rebollo I, Hendrickx APA, Willems RJL, Breukink E, Martin NI. identification of lipid II binding lipopeptides with antibacterial activity against vancomycin-resistant bacteria. Chemical Science. 8: 7991-7997. PMID 29568446 DOI: 10.1039/C7Sc03413J  0.783
2017 Brown JI, Koopmans T, van Strien J, Martin NI, Frankel A. Kinetic analysis of PRMT1 reveals multifactorial processivity and a sequential ordered mechanism. Chembiochem : a European Journal of Chemical Biology. PMID 29112789 DOI: 10.1002/Cbic.201700521  0.755
2017 Kleijn LHJ, Vlieg HC, Wood TM, Sastre Toraño J, Janssen BJC, Martin NI. High-resolution crystal structure reveals molecular details of target recognition by the calcium-dependent lipopeptide antibiotic laspartomycin C. Angewandte Chemie (International Ed. in English). PMID 29108098 DOI: 10.1002/Anie.201709240  0.314
2017 Tehrani KHME, Martin NI. Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem. Acs Infectious Diseases. PMID 28820574 DOI: 10.1021/Acsinfecdis.7B00094  0.362
2017 van Haren MJ, Taig R, Kuppens J, Sastre Toraño J, Moret EE, Parsons RB, Sartini D, Emanuelli M, Martin NI. Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state. Organic & Biomolecular Chemistry. PMID 28758655 DOI: 10.1039/C7Ob01357D  0.354
2017 le Paige UB, Smits B, 't Hart P, Lefeber F, Martin NI, van Ingen H. Weak coupling between magnetically inequivalent spins: The deceptively simple, complicated spectrum of a (13)C-labeled trimethylated amine. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 278: 96-103. PMID 28391179 DOI: 10.1016/J.Jmr.2017.03.016  0.717
2017 van Haren MJ, Marechal N, Troffer-Charlier N, Cianciulli A, Sbardella G, Cavarelli J, Martin NI. Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1. Proceedings of the National Academy of Sciences of the United States of America. PMID 28330993 DOI: 10.1073/Pnas.1618401114  0.332
2017 Sevšek A, Šrot L, Rihter J, Čelan M, van Ufford LQ, Moret EE, Martin NI, Pieters RJ. N-Guanidino Derivatives of 1,5-Dideoxy-1,5-imino-d-xylitol are Potent, Selective, and Stable Inhibitors of β-Glucocerebrosidase. Chemmedchem. PMID 28328014 DOI: 10.1002/Cmdc.201700050  0.593
2017 van Harten RM, Willems RJ, Martin NI, Hendrickx AP. Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies? Trends in Microbiology. PMID 28209400 DOI: 10.1016/J.Tim.2017.01.004  0.376
2017 Brown JI, Koopmans T, van Strien J, Martin NI, Frankel A. Cover Feature: Kinetic Analysis of PRMT1 Reveals Multifactorial Processivity and a Sequential Ordered Mechanism (ChemBioChem 1/2018) Chembiochem. 19: 2-2. DOI: 10.1002/Cbic.201700645  0.713
2016 Oude Blenke E, Sleszynska M, Evers M, Storm G, Martin NI, Mastrobattista E. Strategies for the activation and release of the membranolytic peptide melittin from liposomes using endosomal pH as a trigger. Bioconjugate Chemistry. PMID 28004569 DOI: 10.1021/Acs.Bioconjchem.6B00677  0.36
2016 Cura V, Marechal N, Troffer-Charlier N, Strub JM, van Haren MJ, Martin NI, Cianférani S, Bonnefond L, Cavarelli J. Structural studies of protein arginine methyltransferase 2 reveal its interactions with potential substrates and inhibitors. The Febs Journal. PMID 27879050 DOI: 10.1111/Febs.13953  0.344
2016 Van 't Veer IL, Leloup N, Egan A, Janssen B, Martin N, Vollmer W, Breukink E. Site specific immobilization of the peptidoglycan synthase PBP1B on a surface plasmon resonance chip surface. Chembiochem : a European Journal of Chemical Biology. PMID 27709766 DOI: 10.1002/Cbic.201600461  0.313
2016 Sevšek A, Čelan M, Erjavec B, Quarles van Ufford L, Sastre Toraño J, Moret EE, Pieters RJ, Martin NI. Bicyclic isoureas derived from 1-deoxynojirimycin are potent inhibitors of β-glucocerebrosidase. Organic & Biomolecular Chemistry. PMID 27604065 DOI: 10.1039/C6Ob01735E  0.585
2016 van Haren MJ, Sastre Torano J, Sartini D, Emanuelli M, Parsons RB, Martin NI. A rapid and efficient assay for the characterization of substrates and inhibitors of nicotinamide N-methyltransferase. Biochemistry. PMID 27570878 DOI: 10.1021/Acs.Biochem.6B00733  0.357
2016 Kleijn LH, Oppedijk SF, 't Hart P, van Harten RM, Martin-Visscher LA, Kemmink J, Breukink E, Martin NI. Total Synthesis of Laspartomycin C and Characterization of its Antibacterial Mechanism of Action. Journal of Medicinal Chemistry. PMID 26967152 DOI: 10.1021/Acs.Jmedchem.6B00219  0.793
2016 Hansenová Maňásková S, Nazmi K, van 't Hof W, van Belkum A, Martin NI, Bikker FJ, van Wamel WJ, Veerman EC. Staphylococcus aureus Sortase A-Mediated Incorporation of Peptides: Effect of Peptide Modification on Incorporation. Plos One. 11: e0147401. PMID 26799839 DOI: 10.1371/Journal.Pone.0147401  0.382
2015 't Hart P, Oppedijk SF, Breukink E, Martin NI. New Insights into Nisin's Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues. Biochemistry. PMID 26653142 DOI: 10.1021/Acs.Biochem.5B01173  0.744
2015 Oppedijk SF, Martin NI, Breukink E. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II. Biochimica Et Biophysica Acta. PMID 26523408 DOI: 10.1016/J.Bbamem.2015.10.024  0.369
2015 Gruba N, Wysocka M, Brzezińska M, Debowski D, Rolka K, Martin N, Lesner A. Novel internally quenched substrate of the trypsin-like subunit of 20S eukaryotic proteasome. Analytical Biochemistry. PMID 26314791 DOI: 10.1016/J.Ab.2015.08.019  0.35
2015 Corradini E, Klaasse G, Leurs U, Heck AJ, Martin NI, Scholten A. Charting the interactome of PDE3A in human cells using an IBMX based chemical proteomics approach. Molecular Biosystems. PMID 26205238 DOI: 10.1039/C5Mb00142K  0.307
2015 Koopmans T, Wood TM, 't Hart P, Kleijn LH, Hendrickx AP, Willems RJ, Breukink E, Martin NI. Semisynthetic Lipopeptides Derived from Nisin Display Antibacterial Activity and Lipid II Binding on Par with That of the Parent Compound. Journal of the American Chemical Society. 137: 9382-9. PMID 26122963 DOI: 10.1021/Jacs.5B04501  0.786
2015 van Haren M, van Ufford LQ, Moret EE, Martin NI. Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites. Organic & Biomolecular Chemistry. 13: 549-60. PMID 25380215 DOI: 10.1039/C4Ob01734J  0.368
2014 Thomas D, Koopmans T, Lakowski TM, Kreinin H, Vhuiyan MI, Sedlock SA, Bui JM, Martin NI, Frankel A. Protein arginine N-methyltransferase substrate preferences for different nη-substituted arginyl peptides. Chembiochem : a European Journal of Chemical Biology. 15: 1607-13. PMID 25044481 DOI: 10.1002/Cbic.201402045  0.771
2014 Mohammadi T, Sijbrandi R, Lutters M, Verheul J, Martin NI, den Blaauwen T, de Kruijff B, Breukink E. Specificity of the transport of lipid II by FtsW in Escherichia coli. The Journal of Biological Chemistry. 289: 14707-18. PMID 24711460 DOI: 10.1074/Jbc.M114.557371  0.323
2014 Mooney CA, Johnson SA, 't Hart P, Quarles van Ufford L, de Haan CA, Moret EE, Martin NI. Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors. Journal of Medicinal Chemistry. 57: 3154-60. PMID 24649802 DOI: 10.1021/Jm401977J  0.761
2014 't Hart P, Kleijn LH, de Bruin G, Oppedijk SF, Kemmink J, Martin NI. A combined solid- and solution-phase approach provides convenient access to analogues of the calcium-dependent lipopeptide antibiotics. Organic & Biomolecular Chemistry. 12: 913-8. PMID 24346297 DOI: 10.1039/C3Ob42238K  0.768
2013 van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM. Cell-penetrating bisubstrate-based protein kinase C inhibitors. Acs Chemical Biology. 8: 1479-87. PMID 23621550 DOI: 10.1021/Cb300709G  0.327
2013 Koopmans T, van Haren M, van Ufford LQ, Beekman JM, Martin NI. A concise preparation of the fluorescent amino acid L-(7-hydroxycoumarin-4-yl) ethylglycine and extension of its utility in solid phase peptide synthesis. Bioorganic & Medicinal Chemistry. 21: 553-9. PMID 23238078 DOI: 10.1016/J.Bmc.2012.10.055  0.765
2013 van Hattum H, Martin NI, Ruijtenbeek R, Pieters RJ. Development of a microarray detection method for galectin cancer proteins based on ligand binding. Analytical Biochemistry. 434: 99-104. PMID 23149235 DOI: 10.1016/J.Ab.2012.11.003  0.532
2013 Kooij R, Branderhorst HM, Bonte S, Wieclawska S, Martin NI, Pieters RJ. Glycosidase inhibition by novel guanidinium and urea iminosugar derivatives Medchemcomm. 4: 387-393. DOI: 10.1039/C2Md20343J  0.601
2012 Koopmans T, Dekker FJ, Martin NI. A photocleavable affinity tag for the enrichment of alkyne-modified biomolecules Rsc Advances. 2: 2244-2246. DOI: 10.1039/C2Ra20082A  0.741
2012 T Hart P, Thomas D, Van Ommeren R, Lakowski TM, Frankel A, Martin NI. Analogues of the HIV-Tat peptide containing Nη-modified arginines as potent inhibitors of protein arginine N-methyltransferases Medchemcomm. 3: 1235-1244. DOI: 10.1039/C2Md20161E  0.39
2011 't Hart P, Lakowski TM, Thomas D, Frankel A, Martin NI. Peptidic partial bisubstrates as inhibitors of the protein arginine N-methyltransferases. Chembiochem : a European Journal of Chemical Biology. 12: 1427-32. PMID 21560220 DOI: 10.1002/Cbic.201100074  0.762
2010 Lakowski TM, 't Hart P, Ahern CA, Martin NI, Frankel A. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases. Acs Chemical Biology. 5: 1053-63. PMID 20701328 DOI: 10.1021/Cb100161U  0.774
2010 Ramtohul YK, Martin NI, Silkin L, James MNG, Vederas JC. ChemInform Abstract: Synthesis of Pseudoxazolones and Their Inhibition of the 3C Cysteine Proteinases from Hepatitis A Virus and Human Rhinovirus-14. Cheminform. 33: no-no. DOI: 10.1002/chin.200239120  0.784
2009 Martin NI, Woodward JJ, Winter MB, Marletta MA. 4,4-Difluorinated analogues of l-arginine and N(G)-hydroxy-l-arginine as mechanistic probes for nitric oxide synthase. Bioorganic & Medicinal Chemistry Letters. 19: 1758-62. PMID 19230661 DOI: 10.1016/J.Bmcl.2009.01.076  0.74
2009 Woodward JJ, Chang MM, Martin NI, Marletta MA. The second step of the nitric oxide synthase reaction: evidence for ferric-peroxo as the active oxidant. Journal of the American Chemical Society. 131: 297-305. PMID 19128180 DOI: 10.1021/Ja807299T  0.655
2009 Martin NI. Concise preparation of tetra-orthogonally protected (2S,6R)-lanthionines. The Journal of Organic Chemistry. 74: 946-9. PMID 19046137 DOI: 10.1021/Jo802415C  0.326
2008 Martin NI, Liskamp RM. Preparation of N(G)-substituted L-arginine analogues suitable for solid phase peptide synthesis. The Journal of Organic Chemistry. 73: 7849-51. PMID 18754641 DOI: 10.1021/Jo801517F  0.381
2008 Martin NI, Beeson WT, Woodward JJ, Marletta MA. N(G)-aminoguanidines from primary amines and the preparation of nitric oxide synthase inhibitors. Journal of Medicinal Chemistry. 51: 924-31. PMID 18220331 DOI: 10.1021/Jm701119V  0.778
2007 Martin NI, Breukink E. Expanding role of lipid II as a target for lantibiotics. Future Microbiology. 2: 513-25. PMID 17927474 DOI: 10.2217/17460913.2.5.513  0.375
2007 Martin NI, Woodward JJ, Winter MB, Beeson WT, Marletta MA. Design and synthesis of C5 methylated L-arginine analogues as active site probes for nitric oxide synthase. Journal of the American Chemical Society. 129: 12563-70. PMID 17892291 DOI: 10.1021/Ja0746159  0.789
2007 Martin NI, Derbyshire ER, Marletta MA. Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1. Bioorganic & Medicinal Chemistry Letters. 17: 4938-41. PMID 17587571 DOI: 10.1016/J.Bmcl.2007.06.039  0.731
2007 Pattabiraman VR, Stymiest JL, Derksen DJ, Martin NI, Vederas JC. Multiple on-resin olefin metathesis to form ring-expanded analogues of the lantibiotic peptide, lacticin 3147 A2. Organic Letters. 9: 699-702. PMID 17286377 DOI: 10.1021/Ol063133J  0.776
2007 Woodward JJ, Martin NI, Marletta MA. An Escherichia coli expression-based method for heme substitution. Nature Methods. 4: 43-5. PMID 17187078 DOI: 10.1038/Nmeth984  0.646
2007 Pattabiraman VR, Stymiest JL, Derksen DJ, Martin NI, Vederas JC. On-Resin Olefin Metathesis Synfacts. 2007: 663-663. DOI: 10.1055/S-2007-968531  0.442
2006 Martin NI, Woodward JJ, Marletta MA. NG-hydroxyguanidines from primary amines. Organic Letters. 8: 4035-8. PMID 16928067 DOI: 10.1021/Ol061454P  0.658
2006 Gursky LJ, Martin NI, Derksen DJ, van Belkum MJ, Kaur K, Vederas JC, Stiles ME, McMullen LM. Production of piscicolin 126 by Carnobacterium maltaromaticum UAL26 is controlled by temperature and induction peptide concentration. Archives of Microbiology. 186: 317-25. PMID 16927067 DOI: 10.1007/S00203-006-0147-Z  0.783
2004 Martin NI, Sprules T, Carpenter MR, Cotter PD, Hill C, Ross RP, Vederas JC. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry. 43: 3049-56. PMID 15023056 DOI: 10.1021/Bi0362065  0.546
2003 Martin NI, Hu H, Moake MM, Churey JJ, Whittal R, Worobo RW, Vederas JC. Isolation, structural characterization, and properties of mattacin (polymyxin M), a cyclic peptide antibiotic produced by Paenibacillus kobensis M. The Journal of Biological Chemistry. 278: 13124-32. PMID 12569104 DOI: 10.1074/Jbc.M212364200  0.559
2002 Garneau S, Martin NI, Vederas JC. Two-peptide bacteriocins produced by lactic acid bacteria. Biochimie. 84: 577-92. PMID 12423802 DOI: 10.1016/S0300-9084(02)01414-1  0.567
2002 Ramtohul YK, Martin NI, Silkin L, James MNG, Vederas JC. Synthesis of pseudoxazolones and their inhibition of the 3C cysteine proteinases from hepatitis A virus and human rhinovirus-14 Journal of the Chemical Society-Perkin Transactions 1. 1351-1359. DOI: 10.1039/B202643K  0.778
2002 Ramtohul YK, Martin NI, Silkin L, James MNG, Vederas JC. Synthesis of pseudoxazolones and their inhibition of the 3C cysteine proteinases from hepatitis A virus and human rhinovirus-14 Journal of the Chemical Society. Perkin Transactions 1. 1351-1359.  0.771
2001 Ramtohul YK, Martin NI, Silkin L, James MNG, Vederas JC. Pseudoxazolones, a new class of inhibitors for cysteine proteinases: inhibition of hepatitis A virus and human rhinovirus 3C proteinases Chemical Communications. 2740-2741. DOI: 10.1039/B109095J  0.774
2001 Ramtohul YK, Martin NI, Silkin L, James MNG, Vederas JC. Pseudoxazolones, a new class of inhibitors for cysteine proteinases: Inhibition of hepatitis A virus and human rhinovirus 3C proteinases Chemical Communications. 2740-2741.  0.774
Show low-probability matches.